Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ABBVIE-INC-12136589/news/AbbVie-Submits-Application-for-Risankizumab-SKYRIZI-in-Moderate-to-Severe-Crohn-s-Disease-to-Eur-37166893/?utm_source=whatsapp&utm_medium=social&utm_campaign=share